Acute respiratory viral infections (ARVI), including influenza, continue to occupy the first place in the structure of all human infectious diseases and remain one of the most relevant medical problems. For the treatment and prevention of acute respiratory viral infections and influenza, drugs of various groups are used. Among the combined drugs today, the preferred drug is grippomix, the effectiveness and safety of which has been studied in this study.  The presence of almost all the necessary active ingredients in a single form used for the complex therapy of acute respiratory viral infections, helped to increase patients' compliance to treatment, facilitating the clinical course of the disease, reducing the risk of complications.

ARVI, influenza, treatment, combined drugs, grippomix.

Dektyareva U.A., Ovsyannikov D.Yu., Zhdanova O.I. Clinical efficacy of a new form of rimantadine in children of "risk groups" of severe influenza and acute respiratory diseases. Attending physician 3. 2010. pp.37-45.

Grippomix: preclinical study of the toxicological safety of the drug / Dubovik B.V., Nerovnya A.M., Nasek V.M., I.A. Zhukova, L.I. Pokachailo L.I. 02.2010.

Kryukova A.I.Kunelskaya N.L., GurovA.V.,Izotova G.N. Cetirizine in the treatment of inflammatory diseases of the nasal cavity Median Council No. 18,2016 pp.110-113.

Lazareva N.B., Zhuravleva M.V., Panteleeva A.R. ARVI. Rational pharmacotherapy. Medical advice. 2016. pp. 68-74.

Prokhorovich E.A. / Acute respiratory viral diseases. Zemsky doctor. No.1. 2010. pp.39-43.

Nikiforov V. V., Suranova T. G., Orlova N. V., Cardonova E. V.,. Smetanina S. V. Algorithms for providing medical care to patients with acute respiratory viral infections. DOI: 10.33667/2078-5631-2019-2-27(402)- 6-13 Medical Alphabet N 27 / 2019, volume No. 2 Modern Polyclinic. pp.6-13.

Picon P.D., Costa M.B., da Veiga Picon R., Fendt L.C., Suksteris M.L., Saccilotto I.C. et al. Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial. BMC Infect Dis. 2013;13:556.

Vorilhon P, Arpajou B, Roussel HV, Merlin E, Pereira B, Cabaillot A. et al. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin linical Pharmacology. 2019;75:303–311.